These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10836288)

  • 1. Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients?
    Barak Y; Kimhi R; Weizman R
    Int Clin Psychopharmacol; 2000 Jan; 15(1):53-6. PubMed ID: 10836288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.
    Karlsson I; Godderis J; Augusto De Mendonça Lima C; Nygaard H; Simányi M; Taal M; Eglin M
    Int J Geriatr Psychiatry; 2000 Apr; 15(4):295-305. PubMed ID: 10767728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy.
    Hochstrasser B; Isaksen PM; Koponen H; Lauritzen L; Mahnert FA; Rouillon F; Wade AG; Andersen M; Pedersen SF; Swart JC; Nil R
    Br J Psychiatry; 2001 Apr; 178():304-10. PubMed ID: 11282808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.
    Peet M
    Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Lepola UM; Loft H; Reines EH
    Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy.
    Klysner R; Bent-Hansen J; Hansen HL; Lunde M; Pleidrup E; Poulsen DL; Andersen M; Petersen HE
    Br J Psychiatry; 2002 Jul; 181():29-35. PubMed ID: 12091260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials.
    Keller MB
    J Clin Psychiatry; 2000 Dec; 61(12):896-908. PubMed ID: 11206593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
    Pallanti S; Quercioli L; Bruscoli M
    J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C
    J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
    McGrath PJ; Khan AY; Trivedi MH; Stewart JW; Morris DW; Wisniewski SR; Miyahara S; Nierenberg AA; Fava M; Rush AJ
    J Clin Psychiatry; 2008 Dec; 69(12):1847-55. PubMed ID: 19026268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.
    Clayton AH; Gommoll C; Chen D; Nunez R; Mathews M
    Int Clin Psychopharmacol; 2015 Jul; 30(4):216-23. PubMed ID: 26039688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in cognitive functioning following acute antidepressant treatment in late-life depression.
    Culang ME; Sneed JR; Keilp JG; Rutherford BR; Pelton GH; Devanand DP; Roose SP
    Am J Geriatr Psychiatry; 2009 Oct; 17(10):881-8. PubMed ID: 19916207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
    Cui M; Huang CY; Wang F
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2905-2918. PubMed ID: 30201459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.
    Bendtsen L; Jensen R; Olesen J
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):285-90. PubMed ID: 8795600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.